These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32750456)

  • 1. The potassium regulator patiromer affects serum and stool electrolytes in patients receiving hemodialysis.
    Amdur RL; Paul R; Barrows ED; Kincaid D; Muralidharan J; Nobakht E; Centron-Vinales P; Siddiqi M; Patel SS; Raj DS
    Kidney Int; 2020 Nov; 98(5):1331-1340. PubMed ID: 32750456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis.
    Bushinsky DA; Rossignol P; Spiegel DM; Benton WW; Yuan J; Block GA; Wilcox CS; Agarwal R
    Am J Nephrol; 2016; 44(5):404-410. PubMed ID: 27784004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial.
    Bakris GL; Pitt B; Weir MR; Freeman MW; Mayo MR; Garza D; Stasiv Y; Zawadzki R; Berman L; Bushinsky DA;
    JAMA; 2015 Jul; 314(2):151-61. PubMed ID: 26172895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patiromer Lowers Serum Potassium When Taken without Food: Comparison to Dosing with Food from an Open-Label, Randomized, Parallel Group Hyperkalemia Study.
    Pergola PE; Spiegel DM; Warren S; Yuan J; Weir MR
    Am J Nephrol; 2017; 46(4):323-332. PubMed ID: 29017162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the Potassium-Binding Polymer Patiromer on Markers of Mineral Metabolism.
    Bushinsky DA; Spiegel DM; Yuan J; Warren S; Fogli J; Pergola PE
    Clin J Am Soc Nephrol; 2019 Jan; 14(1):103-110. PubMed ID: 30381412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Patiromer on Hyperkalemia Recurrence in Older Chronic Kidney Disease Patients Taking RAAS Inhibitors.
    Weir MR; Bushinsky DA; Benton WW; Woods SD; Mayo MR; Arthur SP; Pitt B; Bakris GL
    Am J Med; 2018 May; 131(5):555-564.e3. PubMed ID: 29180023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Patiromer in Hyperkalemic Patients Taking and Not Taking RAAS Inhibitors.
    Kloner RA; Gross C; Yuan J; Conrad A; Pergola PE
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):524-531. PubMed ID: 30103622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Pharmacodynamic Effects of the Potassium Binder RDX7675 in Mice.
    Davidson JP; King AJ; Kumaraswamy P; Caldwell JS; Korner P; Blanks RC; Jacobs JW
    J Cardiovasc Pharmacol Ther; 2018 May; 23(3):244-253. PubMed ID: 29130735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patiromer Treatment in Patients With CKD, Hyperkalemia, and Hyperphosphatemia: A Post Hoc Analysis of 3 Clinical Trials.
    Bushinsky DA; Budden JJ; Kalra PA; Yuan J; Quinn CM; Epstein M
    Am J Kidney Dis; 2023 Jul; 82(1):97-104. PubMed ID: 36965827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
    Weir MR; Bakris GL; Gross C; Mayo MR; Garza D; Stasiv Y; Yuan J; Berman L; Williams GH
    Kidney Int; 2016 Sep; 90(3):696-704. PubMed ID: 27350174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patiromer for Treatment of Hyperkalemia in the Emergency Department: A Pilot Study.
    Rafique Z; Liu M; Staggers KA; Minard CG; Peacock WF
    Acad Emerg Med; 2020 Jan; 27(1):54-60. PubMed ID: 31599043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Patiromer on Urinary Ion Excretion in Healthy Adults.
    Bushinsky DA; Spiegel DM; Gross C; Benton WW; Fogli J; Hill Gallant KM; Du Mond C; Block GA; Weir MR; Pitt B
    Clin J Am Soc Nephrol; 2016 Oct; 11(10):1769-1776. PubMed ID: 27679518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors.
    Weir MR; Bakris GL; Bushinsky DA; Mayo MR; Garza D; Stasiv Y; Wittes J; Christ-Schmidt H; Berman L; Pitt B;
    N Engl J Med; 2015 Jan; 372(3):211-21. PubMed ID: 25415805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-World Evaluation of Patiromer for the Treatment of Hyperkalemia in Hemodialysis Patients.
    Kovesdy CP; Rowan CG; Conrad A; Spiegel DM; Fogli J; Oestreicher N; Connaire JJ; Winkelmayer WC
    Kidney Int Rep; 2019 Feb; 4(2):301-309. PubMed ID: 30775627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing patiromer utilization and associated serum potassium changes in US veterans with prior sodium polystyrene sulfonate exposure.
    Patel S; Pinnell D; Qualls J; Rathod A; Chen W; Boutin S; Woods SD; Kovesdy CP; Tangri N; Sauer BC
    Medicine (Baltimore); 2023 Mar; 102(9):e33134. PubMed ID: 36862858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Patiromer Monotherapy for Hyperkalemia in an Acute Care Setting.
    Di Palo KE; Sinnett MJ; Goriacko P
    JAMA Netw Open; 2022 Jan; 5(1):e2145236. PubMed ID: 35080601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia.
    Bushinsky DA; Williams GH; Pitt B; Weir MR; Freeman MW; Garza D; Stasiv Y; Li E; Berman L; Bakris GL
    Kidney Int; 2015 Dec; 88(6):1427-1433. PubMed ID: 26376130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Rare Case of Patiromer Induced Hypercalcemia.
    Kanduri SR; Suchow KJ; Velez JCQ
    J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34442051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of infant formula with patiromer dose dependently decreases potassium concentration.
    Paloian NJ; Bowman B; Bartosh SM
    Pediatr Nephrol; 2019 Aug; 34(8):1395-1401. PubMed ID: 30963285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Potassium Dialysate as a Protective Factor of Sudden Cardiac Death in Hemodialysis Patients with Hyperkalemia.
    Huang CW; Lee MJ; Lee PT; Hsu CY; Huang WC; Chen CL; Chou KJ; Fang HC
    PLoS One; 2015; 10(10):e0139886. PubMed ID: 26440515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.